Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ASPN vs HDSN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HDSN Captures Overall Composite Edge (53.2 HOLD vs 46.3 HOLD), While ASPN Leads 4–2 on Growth & Valuation Pillars

HDSN Overall Winner 6-Pillar Tally: ASPN 4 – 2 HDSN Matrix Metrics: ASPN 3 – 7 HDSN

As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Aspen Aerogels, Inc. (ASPN) on higher Unified Composite conviction (53.2/100 HOLD vs. 46.3/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Profitability & Quality), while ASPN wins 4–2 across the 6-pillar growth and valuation breakdown. ASPN trades at $5.14 (N/M Forward P/E, -22.2% operating margin) versus HDSN at $4.25 (25.9x Forward P/E, 2.0% operating margin).

  • Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. ASPN 46.3/100 HOLD) and 1.32β · 68% Vol risk profile, whereas ASPN leads top-line expansion (+16.7% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: ASPN trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 46.4); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ASPN vs HDSN
ASPN NYSE
Aspen Aerogels, Inc.
Wholesale-Lumber & Other Construction Materials
$5.14
-7.8% 1D
Market Cap $456.0M
TTM Revenue $214M
Forward P/E N/M
Beta / 30D Vol 1.97β · 124% Vol
Unified Composite Score
46.3 / 100 HOLD
Tech 28.0 Fund 43.0 Flow 58.0 Mom 56.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.4 · SMA20: $5.40 · SMA50: $5.34
HDSN NASDAQ Head-to-Head Winner
Hudson Technologies Inc
Wholesale-Machinery, Equipment & Supplies
$4.25
-3.52% 1D
Market Cap $186.5M
TTM Revenue $242M
Forward P/E 25.9x
Beta / 30D Vol 1.32β · 68% Vol
Unified Composite Score
53.2 / 100 HOLD
Tech 67.0 Fund 65.0 Flow 55.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 35
RSI-14: 34.9 · SMA20: $4.68 · SMA50: $4.99

6-Pillar Scorecard Institutional Category Breakdown (ASPN 4 – 2 HDSN)

Columns: Metric · ASPN · HDSN
1. Valuation Multiples HDSN
Forward P/E N/M 25.9x
Trailing P/E N/M 16.5x
PEG Ratio N/M 0.29x
EV / Revenue 2.0x 0.6x
2. Growth & Scale ASPN
Revenue Growth (YoY) +16.7% -19.7%
Earnings Growth (YoY) +0.0% -82.0%
TTM Revenue (USD) $214M $242M
Market Cap $456.0M $186.5M
3. Profitability & Quality HDSN
Gross Margin 22.3% 21.0%
Operating Margin -22.2% 2.0%
Net Profit Margin -60.8% -0.5%
Return on Equity (ROE) -53.2% -0.5%
4. Balance Sheet & Cash Flow ASPN
Cash Generation (TTM) $20M -$32M
Cash Flow Margin 9.3% -13.0%
Net Cash / Leverage $30M Net Cash $31M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ASPN
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 41.1% (<1st %ile) 79.1% (15th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat ASPN
OpEx & R&D Intensity 44.5% of Rev ($95M) 19.0% of Rev ($46M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Specialty Chemicals Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ASPN (3) vs HDSN (7)
Institutional Metric ASPN HDSN Criterion Row Edge
Market Capitalization
Scale
$456.0M $186.5M Larger Scale ASPN
Trailing P/E Ratio
Valuation
N/M 16.5x Lower Multiple HDSN
Forward P/E Ratio
Valuation
N/M 25.9x Lower Multiple HDSN
Revenue Growth (YoY)
Growth
+16.7% -19.7% Higher Growth ASPN
Operating Margin (TTM)
Profitability
-22.2% 2.0% Higher Margin HDSN
Net Profit Margin
Profitability
-60.8% -0.5% Higher Margin HDSN
Return on Equity (ROE)
Capital Efficiency
-53.2% -0.5% Higher ROE HDSN
52-Week Range Position
Momentum
49% ($2–$8) 6% ($4–$8) Stronger Trend ASPN
Beta / 30D Volatility
Risk Regime
1.97β · 124% Vol 1.32β · 68% Vol Lower Realized Risk HDSN
Unified Institutional Score
Composite Signal
46.3 / 100 (HOLD) 53.2 / 100 (HOLD) Higher Composite HDSN
Trailing 12M Revenue (USD)
Operating Scale
$214M $242M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
22.3% 21.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.0x EV/Rev 0.29x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$20M ($30M Net Cash) -$32M ($31M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ASPN +14.4 pp
ASPN: -0.87% · HDSN: -15.27%
3M Horizon ASPN +16.87 pp
ASPN: -7.8% · HDSN: -24.67%
6M Horizon ASPN +10.77 pp
ASPN: -3.47% · HDSN: -14.24%
1Y Horizon ASPN +97.9 pp
ASPN: +59.78% · HDSN: -38.12%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period ASPN Revenue HDSN Revenue ASPN Op. Margin HDSN Op. Margin Margin Leader
FY2018 $100M $170M -32.5% -25.6% HDSN
FY2019 $140M $160M -10.2% -9.7% HDSN
FY2020 $100M $150M -21.5% 4.0% HDSN
FY2021 $120M $190M -33.4% 21.9% HDSN
FY2022 $180M $330M -43.9% 40.4% HDSN
FY2023 $240M $290M -20.6% 27.0% HDSN
FY2024 $450M $240M 12.0% 12.4% HDSN
FY2025 $270M $250M -139.5% 7.5% HDSN

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ASPN CONSOLIDATION
118d in phase · OBV NEUTRAL
Current IV 41.1%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ASPN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HDSN BREAKDOWN
90d in phase · OBV ACCUMULATION
Current IV 79.1%
IV Percentile 15th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact HDSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ASPN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $456.0M market capitalization and -22.2% operating margin.
OpEx & R&D Reinvestment 44.5% of Rev ($95M)
90D Engineering Disclosures 0 Published
HDSN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $186.5M market capitalization and 2.0% operating margin.
OpEx & R&D Reinvestment 19.0% of Rev ($46M)
90D Engineering Disclosures 0 Published

Investor FAQ ASPN vs HDSN Key Questions & Quantitative Answers

As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Aspen Aerogels, Inc. (ASPN) on higher Unified Composite conviction (53.2/100 HOLD vs. 46.3/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Profitability & Quality), while ASPN wins 4–2 across the 6-pillar growth and valuation breakdown. ASPN trades at $5.14 (N/M Forward P/E, -22.2% operating margin) versus HDSN at $4.25 (25.9x Forward P/E, 2.0% operating margin). Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. ASPN 46.3/100 HOLD) and 1.32β · 68% Vol risk profile, whereas ASPN leads top-line expansion (+16.7% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: ASPN trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 46.4); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ASPN leads the Growth & Scale pillar: ASPN posts +16.7% YoY revenue growth and +0.0% YoY earnings growth on $214M TTM revenue (22.3% gross margin, -22.2% operating margin), compared with HDSN at -19.7% YoY revenue growth and -82.0% YoY earnings growth on $242M TTM revenue (21.0% gross margin, 2.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ASPN cumulative revenue shifted +170.0% while HDSN shifted +47.1%. In operating R&D and SG&A reinvestment, ASPN deploys 44.5% of Rev ($95M) (0 90-day corporate R&D disclosures) versus 19.0% of Rev ($46M) (0 disclosures) for HDSN.

HDSN screens cheaper on headline valuation multiples. ASPN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 2.0x EV/Revenue (9.3% FCF margin), whereas HDSN trades at 25.9x Forward P/E, 16.5x Trailing P/E, 0.29x PEG, and 0.6x EV/Revenue (-13.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ASPN (-53.2% ROE) versus HDSN (-0.5% ROE) capital efficiency.

In options market volatility and institutional positioning, ASPN carries 41.1% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.97β · 124% Vol realized risk). By comparison, HDSN carries 79.1% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.32β · 68% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.